These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7249397)

  • 1. Interaction of HLA and Gm in autoimmune chronic active hepatitis.
    Whittingham S; Mathews JD; Schanfield MS; Tait BD; Mackay IR
    Clin Exp Immunol; 1981 Jan; 43(1):80-6. PubMed ID: 7249397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA and Gm genes in systemic lupus erythematosus.
    Whittingham S; Mathews JD; Schanfield MS; Tait BD; Mackay IR
    Tissue Antigens; 1983 Jan; 21(1):50-7. PubMed ID: 6404002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
    Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
    Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenetic studies of autoimmune chronic active hepatitis: HLA, immunoglobulin allotypes and autoantibodies.
    Krawitt EL; Kilby AE; Albertini RJ; Schanfield MS; Chastenay BF; Harper PC; Mickey RM; McAuliffe TL
    Hepatology; 1987; 7(6):1305-10. PubMed ID: 3500102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis.
    Nouri-Aria KT; Donaldson PT; Hegarty JE; Eddleston AL; Williams R
    J Hepatol; 1985; 1(3):235-41. PubMed ID: 2933448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus nephritis.
    Stenszky V; Kozma L; Szegedi G; Farid NR
    J Immunogenet; 1986 Feb; 13(1):11-7. PubMed ID: 3091700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin genes, HLA-B8/DR3, and immune responsiveness to primary immunogen and mitogens in normal subjects.
    Kallenberg CG; Klaassen RJ; Westra J; Beelen JM; Ockhuizen T
    Clin Immunol Immunopathol; 1988 Jun; 47(3):333-42. PubMed ID: 3259481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gene interaction on susceptibility to disease.
    Whittingham S; Mathews JD; Schanfield MS; Tait BD; Mackay IR
    Tissue Antigens; 1981 Feb; 17(2):252-4. PubMed ID: 7233423
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies.
    Mackay IR; Tait BD
    Gastroenterology; 1980 Jul; 79(1):95-8. PubMed ID: 7380229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma.
    Willcox N; Demaine AG; Newsom-Davis J; Welsh KI; Robb SA; Spiro SG
    Hum Immunol; 1985 Sep; 14(1):29-36. PubMed ID: 2993207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin (Gm) allotype frequencies in patients with renal failure.
    Demaine AG; Vaughan RW; Welsh KI
    Transplantation; 1982 Sep; 34(3):153-4. PubMed ID: 7135469
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens in chronic active hepatitis.
    Pár A; Bajtai G; Gyódi E; Ambrus M; Hernádi E; Tényi I
    Acta Med Acad Sci Hung; 1980; 37(1):17-24. PubMed ID: 7457016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-C genes and susceptibility to type 1 autoimmune hepatitis.
    Strettell MD; Thomson LJ; Donaldson PT; Bunce M; O'Neill CM; Williams R
    Hepatology; 1997 Oct; 26(4):1023-6. PubMed ID: 9328330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gm allotypes in IgA deficiency.
    Hammarström L; Grubb R; Smith CI
    J Immunogenet; 1985 Jun; 12(3):125-30. PubMed ID: 3867712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin (Gm) markers and alpha 1-antitrypsin (PI) types in rheumatoid arthritis and early onset chronic active hepatitis.
    Walsh LJ; Cox DW
    J Immunogenet; 1984 Apr; 11(2):115-20. PubMed ID: 6427355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determinants of autoimmune chronic active hepatitis.
    Mackay IR; Whittingham S; Mathews JD; Tait BD
    Springer Semin Immunopathol; 1980 Dec; 3(3):285-96. PubMed ID: 7022711
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction between HLA antigens and immunoglobulin (Gm) allotypes in susceptibility to type I diabetes.
    Tait BD; Propert DN; Harrison L; Mandel T; Martin FI
    Tissue Antigens; 1986 May; 27(5):249-55. PubMed ID: 3726861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
    Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
    Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ; Rakela J; Hay JE; Moore SB
    Gastroenterology; 1990 Jun; 98(6):1587-93. PubMed ID: 2338197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.